Reversible Lesion in The splenium of The Corpus Callosum Induced by Topiramate in a Patient with Migraine.
10.17340/jkna.2017.35.3.13
- Author:
Deokhyun HEO
1
;
Seung Keun LEE
;
Jeong Ho PARK
;
Tae Kyeong LEE
Author Information
1. Department of Neurology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea. parkgene@schmc.ac.kr
- Publication Type:Case Report
- Keywords:
Splenium;
Migraine;
Topiramate
- MeSH:
Anticonvulsants;
Corpus Callosum*;
Epilepsy;
Humans;
Migraine Disorders*
- From:Journal of the Korean Neurological Association
2017;35(3):173-175
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Reversible lesion in the splenium of the corpus callosum in patients with epilepsy is often associated with some antiepileptic drugs. However, topiramate has never been reported as a possible inducer of the focal lesion. We report a case of reversible splenial lesion of the corpus callosum presumed to be induced by low dose topiramate in a patient with chronic migraine.
